23. CBD products that meet up with the definition of the CBPM will likely be Class B managed medicine and matter to Regulation 16A and also the appropriate restrictions for Plan two drugs [footnote 5]. CBD products that satisfy the definition of the cannabis-centered drugs that has been separately scheduled might be Class B medication in the suitab